文献速递关节外科创伤骨科

全髋关节置换术后异位骨化预防:400与700 cGy随机试验

Heterotopic Ossification Prophylaxis After Total Hip Arthroplasty: Randomized Trial of 400 vs 700 cGy.
PubMed 文献 · J Arthroplasty · 2016-11-01

该随机双盲临床试验纳入147例在全髋关节置换术后存在异位骨化高风险的患者,比较单次400 cGy与700 cGy术后放疗的预防效果。结果显示接受400 cGy的患者异位骨化进展比例显著高于700 cGy组,无伤口并发症。作者认为在高风险人群中700 cGy优于400 cGy,可能为更有效的治疗方案,并建议进一步研究比较700 cGy与400至700 cGy之间的剂量。

要点

  • 在高风险全髋关节置换患者中,400 cGy组异位骨化进展比例显著高于700 cGy组。
  • 两组均未出现伤口并发症。
  • 作者认为700 cGy优于400 cGy,并建议进一步研究比较700 cGy与400至700 cGy之间的剂量。

核心结论

  • 在高风险患者全髋关节置换术后预防异位骨化方面,700 cGy优于400 cGy,可能为该人群更有效的治疗。
  • 作者建议进一步研究比较700 cGy与400至700 cGy之间的剂量,以明确是否可确定更优剂量。

研究设计与样本

  • 随机双盲临床试验,在城市医疗中心纳入147例接受全髋关节置换且异位骨化高风险的患者。
  • 高风险定义为弥漫性特发性骨肥厚、肥厚性骨关节炎、强直性脊柱炎诊断或既往异位骨化史。
  • 患者随机接受术后单次400 cGy或700 cGy放疗,放疗于术后第1或第2天进行。
  • 由一名单盲评估者使用Brooker分级对术后即刻及术后至少6个月的X线片进行分级,进展定义为Brooker分级增加。

主要发现

  • 接受400 cGy的患者中异位骨化进展的比例显著高于接受700 cGy的患者。
  • 无伤口并发症。
  • 无术前因素与更高的进展率相关。
  • 进展患者在体格检查中的屈曲度小于未进展患者,但无临床显著性。

关键数值与推荐

  • 进展定义为Brooker分级增加。
  • 放疗剂量为单次400 cGy或700 cGy,于术后第1或第2天给药。
  • 影像学评估时间为术后即刻及术后至少6个月。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者建议进一步研究比较700 cGy与400至700 cGy之间的剂量,以明确是否可确定更优剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heterotopic ossification (HO) is a known complication following total hip arthroplasty. Radiation is an effective prophylaxis, but an optimal protocol has yet to be determined. We performed a randomized, double-blinded clinical trial in high-risk patients to determine the efficacy of 400 vs 700 cGy doses of radiation. METHODS: One hundred forty-seven patients undergoing total hip arthroplasty and at high risk for HO at an urban medical center were randomized to receive either a single 400 or 700 cGy dose of radiation postoperatively. High risk was defined as a diagnosis of diffuse idiopathic skeletal hyperostosis, hypertrophic osteoarthritis, ankylosing spondylitis, or history of previous HO. Radiation was administered on the first or second postoperative day. A single blinded reviewer graded radiographs taken immediately postoperatively and at a minimum of 6 months postoperatively using the Brooker classification. Progression was defined as an increase in Brooker classification. Operative data including surgical approach, implant fixation, revision surgery, and postoperative range of motion data were also collected. RESULTS: A significantly greater portion of patients who received the 400 cGy dose demonstrated progression of HO than patients who received the 700 cGy dose. There were no wound complications. No preoperative factors were associated with a higher rate of progression. Patients who progressed had less flexion on physical examination than patients who did not progress, but this was not clinically significant. CONCLUSION: Seven hundred centigray was superior to 400 cGy in preventing HO formation following total hip arthroplasty in high-risk patients and may be the more effective treatment in this population. Further studies comparing 700 cGy to dosages between 400 and 700 cGy may help to clarify if a more optimal dose can be identified.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Liu JZ, Frisch NB, Barden RM, et al. Heterotopic Ossification Prophylaxis After Total Hip Arthroplasty: Randomized Trial of 400 vs 700 cGy. J Arthroplasty. 2016. PMID: 27884418. doi:10.1016/j.arth.2016.10.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。